Sotera Health 2024 revenue rises 4.9% to $1.10 billion; net income falls to $44 million
Sotera Health reported fourth-quarter and full-year 2024 results and issued its initial 2025 outlook. Full-year net revenues rose 4.9% to $1.10 billion, but net income fell from $51 million to $44 million and Adjusted EPS declined $0.02 to $0.70. The company expects 2025 net revenue growth of 4.0% to 6.0% and Adjusted EPS of $0.70 to $0.76.
Key points
- Fourth-quarter 2024 net revenues fell 6.5% to $290 million; net income was $12 million, or $0.04 per diluted share, versus $39 million a year earlier.
- Full-year 2024 diluted EPS was $0.16 versus $0.18 in 2023; Adjusted EPS was $0.70.
- 2025 outlook: net revenue growth of 4.0% to 6.0% and Adjusted EPS of $0.70 to $0.76, with net revenue growth on a constant currency basis.
- Nordion fourth-quarter net revenues fell 28.9% to $57 million, which the company attributed to the timing of cobalt harvest schedules.
The filing
Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.